Blair Robes Recall- 162,000 women’s robes recalled after 6 deaths

Consumers are being urged to immediately stop wearing a certain type of chenille robe made by Blair LLC due to a fire hazard that is believed to have killed at least six people.

The Consumer Product Safety Commission and Blair LLC, based in Warren, Pa., on Thursday said they were issuing the second recall notice in two months after receiving reports of six deaths due to the robes catching on fire. In five of the six cases, the victims were women who were cooking at the time; three of the victims were in their 80s. The recall applied to 162,000 robes.

“CPSC urges all consumers to report any incidents or injuries involving consumer products, even after a recall has been announced,” said acting CPSC Chairman Thomas Moore. “Contact the CPSC so that we may help prevent tragic deaths or injuries like those that might be related to the Blair robes.”
CPSC and Blair initially announced their voluntary recall in April, citing three reports of the robes catching on fire, including one report of second-degree burns.

The robes, made in Pakistan, have the following item numbers: 3093111, 3093112, 3093113, 3093114, 3093115, and 3093116. They are a one-piece garment made of plush sculpted chenille, a shaped stand collar, and horizontal chenille front and back yolks and cuffs. The robes have a full-button front with seven matching button closures.

The robes were sold in Blair catalogs and on the company Web site, as well as Blair stores in Warren, Pa., Grove City, Pa., and Wilmington, Del., from January 2003 through March 2009. Consumers may return the robe to Blair and receive a refund or a $50 gift card by contacting the company at (877) 392-7095 between 9 a.m. and 9 p.m. ET Monday through Saturday, via the firm’s Web site at Blair.com/recall, or by e-mail at blairproductrecall(at)blair.com.

Hydroxycut Recall Information – 5/2/2009

Products included in the Hydroxycut Recall

• Hydroxycut Regular Rapid Release Caplets
• Hydroxycut Caffeine-Free Rapid Release Caplets
• Hydroxycut Liquid Shots
• Hydroxycut Hardcore RTDs (Ready-to-Drink)
• Hydroxycut Max Aqua Shed
• Hydroxycut Hardcore Liquid Capsules
• Hydroxycut Max Liquid Capsules
• Hydroxycut Regular Drink Packets
• Hydroxycut Caffeine-Free Drink Packets
• Hydroxycut Hardcore Drink Packets (Ignition Stix)
• Hydroxycut Max Drink Packets
• Hydroxycut 24
• Hydroxycut Carb Control
• Hydroxycut Natural

Users of Hydroxycut should be aware of symptoms of possible liver damage from hydroxycut, including, jaundice, brown urine, nausea, vomiting, light-colored stools, excessive fatigue, weakness, stomach or abdominal pain, itching, and loss of appetite.

Hydroxycut liver failure, injury and death – FDA Warning

May 1 , 2009 – FDA Recall of Hydroxycut due to kidney and liver failure, cardiovascular disorders and even death

As millions of people in the United States attempt to lose weight for a plethora of reasons, many are turning to different products to help them do so. As a result, companies are beginning to research, develop and market these products as a way to accomplish the weight loss they desire in a fast and safe manner.

Unfortunately, some of these weight loss aids are proving to be dangerous, and that appears to be the case with one of the most popular product lines on the market – Hydroxycut products by Iovate Health Sciences, Inc. Below is a brief overview of the burgeoning issue with these products:

The Products

The products at issue are the line of Hydroxycut weight loss aids that are marketed to help consumers weight-loss, as fat burners, as energy-enhancers, as low carb diet aids, and for water loss, all of which are meant to promote better health because of less weight. These products sold in huge numbers since hitting the market, and they are seen as cost-effective and efficient.

The Problems

The problems that have arisen in response to using them have been not only numerous, but serious in nature.

Specifically, these problems include:

• Seizures
• Cardiovascular disorders
• Rhabdomyolysis – A type of muscle damage that can lead to other serious health problems such as kidney failure.

Perhaps most serious is the trend that points towards different forms of liver damage. These different forms of damage include jaundice and elevated liver enzymes, which can lead to the immediate need for a liver transplant.

At this point, at least 23 reports of serious side effects developing as a result of using these products and one death has been reported. Given the small sample pool and the relatively short amount of time in which they have been generated, the US Food and Drug Administration (FDA) has decided to act now.

FDA’s Response

The FDA has recently issued a public warning to all consumers that they should immediately stop using any of these products until additional investigations can be completed regarding Hydroxycut weight loss products. This investigation centers on the ingredients present in the products and other factors included with their usage.

If you or someone you love has been harmed as a result of using Hydroxycut weight loss products, contact a defective drugs lawyer as soon as possible to schedule a free initial consultation.

Bone Screw Recall – Calaxo Screws

Smith & Nephew Inc. is recalling all lot numbers and all item codes of CALAXO screws which were
first distributed in the UK in 2006. This screw is used to secure the graft in anterior cruciate
ligament (ACL) reconstruction.

Worldwide, 0.3% of patients have developed pre-tibial soft tissue swelling, which can mimic the
appearance of an infection between 2 and 36 weeks after implantation. The manufacturer is
currently investigating the cause of this problem.

Most cases resolved without intervention. A small number of cases needed local debridement and
removal of any remaining screw fragments, or replacement with an alternative screw or bone graft.
The manufacturer estimates that about 2,550 devices have been used in the UK since 2006.
The manufacturer is aware of seven reported cases of inflammation in the UK of which two
required implant revision.

The manufacturer wrote to chief executive officers of trusts, theatre managers, and surgeons who
were known to use CALAXO about this product recall in August 2007 (see MHRA website). This
notice is to facilitate the recall.

Digoxin Recall – Caraco Brand

Caraco Pharmaceutical Laboratories and FDA notified healthcare professionals of a consumer-level recall of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011.

The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin, a drug product used to treat heart failure and abnormal heart rhythms. The drug has a narrow therapeutic index and the existence of higher than labeled dose may pose a risk of digoxin toxicity in patients with renal failure.

Digoxin toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia. Death can also result from excessive digoxin intake. A lower than labeled dose may pose a risk of lack of efficacy potentially resulting in cardiac instability.

Consumers with the recalled product should return these products to their pharmacy or place of purchase.

Pistachios Recall Salmonella Warning

A California pistachio processor issued a nationwide voluntary recall on Tuesday of pistachios due to potential salmonella contamination.

The U.S. Food and Drug Administration and the California Dept. of Public Health are investigating the matter. Thus far, several illnesses have been reported by consumers that may be associated with the pistachios, the FDA said.

The recalled nuts were shipped on or after Sept. 1, 2008 by Setton Pistachio of Terra Bella Inc.

Propafenone HCL Tablets Recall

Propafenone HCL Tablets 225 mg Recall

Recalled lot number: 112680A, expiration date July 31, 2010
Product Name: Propafenone HCL tablets
Shipped: Between October 15, 2008 and November 26, 2008.

The lot is being recalled because some tablets may contain slightly higher levels of the active ingredient than specified. The recalled tablets were manufactured by Watson Laboratories, Inc.

Because it has a narrow therapeutic index, some patients who are particularly sensitive to small variations in dose may experience potentially , including arrhythmias (irregular heartbeat) or low blood pressure.

Propafenone is a drug product used to treat cardiac arrhythmias (irregular heartbeats). It has a narrow therapeutic index, so some patients who are particularly sensitive to small variations in dose may experience potentially serious side effects, including arrhythmias (irregular heartbeat) or low blood pressure. Consequently, as a precautionary measure, Watson is recalling this one lot to the consumer level to minimize any potential risk to patients.

Anyone who has 225 mg Propafenone HCL tablets should check the bottle for the lot number and expiration date to see if they have tablets being recalled. Anyone with 225 mg Propafenone HCL tablets being recalled should call (888) 352-9616, Monday through Friday, 8:00 a.m.-5:00 p.m. EDT, for instructions on how to return affected product.

Patients using 225 mg Propafenone HCL tablets who have medical questions should contact their health-care provider.

Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch Web site at www.fda.gov/medwatch

Baxter Infusion Pump Recall

A Class 1 Recall of  Baxter infusion pumps by the FDA.

Colleague Single and Triple Channel Volumetric Infusion Pumps by Baxter
The Model numbers are:

• Mono 2M8151 and 2M8153

• CX 2M8161 and 2M8163

• CXE 2M9161 and 2M9163

The defective Pumps were manufactured and distributed from February, 1997 through December, 2008.

The company identified software and battery usage failures that result in a delay in or interruption of infusion that may cause serious injury and/or death. Baxter sent a letter to all of its customers, which included advice and instructions to institutions using the infusion pumps.

Serrano & Jalepeno Peppers Recall – Salmonella

July 19, 2008 -

Grande Produce, LTD. CO of Hidalgo, Texas (hereinafter referred to as Grande Produce) is recalling Jalepeno Peppers and Serrano Peppers distributed between May 17th and July 17th, 2008; and Avocados, all sizes, with lot #HUE08160090889 because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

The Jalapeno Peppers, Serrano Peppers and Avocados were distributed to the following states: TX, DE, NC, GA, OK, IA, MN, IL, FL, IN, MD, NY, MS, AR, KS, and KY.

The avocados being recalled were shipped in boxes labeled “Frutas Finas de Tancitaro HASS Avocados, Produce of Mexico,” all sizes, with lot number HUE08160090889. The Jalapeno Peppers and Serrano peppers being recalled were shipped in 35lb. plastic crates with no brand name or label.

No illnesses associated with this recall have been reported to date.

The recall is a result of sampling by the Texas Department of State Health Services and The North Carolina Department of Health and Human Services, which revealed that these products contained the bacteria. Distribution of these products has been suspended while FDA, the Texas Department of State Health Services, The North Carolina Department of Health and Human Services and the company continue their investigation as to the source of the problem.

Consumers who purchased Avocados, Jalapeno Peppers and Serrano Peppers should contact their supplier to determine if their products are involved in the recall. Consumers with questions may contact the company at (956) 843-8575.

Toy Recall – Lead found in “Faded Glory” Bracelet

Lead is still being found in many popular children’s toys and items. It is thankful that this is being discovered since exposure to lead can be very harmful to a child’s health.

July 10th the U.S. Consumer Product Safety Commission in agreement with Wal-Mart Stores Inc. of Bentonville, Arkansas announced a voluntary recall on the “Faded Glory” Lip Gloss, Locket, and Bracelet Sets sold exclusively at Wal-Mart across the nation.

High levels of lead were found in the lobster claw clasp located on the charm bracelet included in this set. The lobster claw clasp is used to close the bracelet around the wrist. If the clasp is ingested, it can cause serious health injuries and/or illnesses. No injuries or incidents have been reported at this time.

This “Faded Glory” set was manufactured in China and sold in Wal-Mart from May 2008 through June 2008 selling for about $6 each. If you are in possession of this item, discontinue any use of this item immediately and return it to Wal-Mart for a full refund.

If you have experienced any adverse side effects after using this product, contact an attorney from our firm that has knowledge of product liability and personal injury.

Morphine Sulfate Recall- Voluntarily Recall by Ethex Corp

ETHEX Corporation announced today that it has voluntarily recalled a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The lot was distributed by ETHEX Corporation under an “ETHEX” label between April 16th and April 27th of 2008. No other dosage strength, nor any other lot of the 60 mg strength is affected by this recall. The voluntary single-lot recall is due to a report that a tablet with as much as double the appropriate thickness was identified and the possibility therefore that there may be other similar oversized tablets that may have been commercially released in the affected lot. Such tablets may contain as much as twice the labeled level of active morphine ingredient. The product is a white oval tablet with “60″ on one side, and “E” on the reverse.

No report of unexpected side effects or injury has been received. However, opioids such as morphine have life-threatening consequences if overdosed. Those consequences can include respiratory depression (difficulty or lack of breathing), and low blood pressure. Many patients for whom this product is prescribed are likely to be highly debilitated with reduced strength or energy as a result of illness. As such, they may be less likely to be able to determine that a tablet is overweight or oversized than an unimpaired individual.

Any customer inquiries related to this action should be addressed to ETHEX Customer Service at 1-800-321-1705, or fax to ETHEX Customer Service at 314-646-3751 or sent via email to: customer-service@ethex.com with representatives available Monday through Friday, 8 am to 5 pm CST.

ETHEX Corporation previously initiated the recall notification to wholesalers and retailers who have received any inventory of the recalled lot of this product with instructions for returning the recalled product and, if they have not already done so, they are urged to contact the number above regarding procedures for returning the recalled product. If consumers have any questions about the recall, they should call the number above, their physician, their pharmacist or other health care provider.

This recall is being conducted with the knowledge of the Food and Drug Administration (FDA).
Any adverse reactions experienced with the use of this product, and/or quality problems may also be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

Consumer Warning: Contaminated Dip

FOR IMMEDIATE RELEASE –Lansing, MI — February 5, 2008
The Michigan Department of Agriculture (MDA) today warned consumers to check their cupboards for Olivier brand Parmesan & Asiago Dip with Garlic & Basil because of the possibility of contamination with Clostridium botulinum. Olivier brand Parmesan & Asiago Dip with Garlic & Basil is manufactured by Olivier Olive Oil Products, Inc. of St. Helena, California, which has initiated a voluntary recall of the product.

Clostridium botulinum is a bacterium which can cause life-threatening illness or death. Symptoms of botulism include: general weakness, dizziness, double-vision and trouble with speaking or swallowing. Difficulty in breathing, weakness of other muscles, abdominal distension and constipation may also be common symptoms. People experiencing these problems should seek immediate medical attention. There have been no reported illnesses.

The product was distributed to William-Sonoma retail stores nationwide and to Olivier Napa Valley retail stores located in Truckee and St. Helena, California. Olivier Parmesan & Asiago Dip with Garlic & Basil labeled with the following lot codes are affected by the recall: OPA 34171; OPA 23471; OAP 17271; OAP 17671; OAP 36061; OAP 36161; OPA 33961.The recalled product is packaged in an 11.76 ounce jar. The lot code information is located on the side of the glass jar where there is no label. Photos of the product are available at www.cdph.ca.gov.

Consumer Warning: Contaminated Dip

Tags: consumer, warning, fda, dip, recall, michigan

Evenflo Car Seat Recall – One Million Discovery Seats Recalled

About one million child safety seats made by Evenflo are being recalled because they could fail to protect children from vehicle side-impacts.The seats being recalled are Evenflo Discovery child safety seat models 390, 391, 534 and 552 made between April 2005 and January 29, 2008. The serial number and date of manufacture can be found on a white label on the underside of the safety seat.

Owners of the affected Discovery safety seats are urged to immediately contact Evenflo and receive a free dual-hook fastener that will secure the seat to its base. Parents should continue using the safety seats while waiting for their fasteners to arrive, said NHTSA.

NHTSA urges parents affected by the recall to contact Evenflo at 1-800-356-2229 between the hours of 8am and 5pm EST, or visit the Evenflo web site: http://safety.evenflo.com/cs/sc/cssc_RD.phtml.

Related Child Car Seat Recall Information

NuCel Eye Drop Recall and Eye Wash Products. Recall

January 31, 2008

The FDA announced a recall to consumers and healthcare professionals about NuCel Labs voluntarily Eye Drop Recall and Eye Wash Products. This is a nationwide recall due to testing which indicated potential bacteria and particulate matter making the products non-sterile. Use of the products poses an unacceptable risk of eye infections and in rare cases blindness or loss of vision.

There are presently no reported injuries and consumers are asked to discontinue use and immediately return the product to NuCel Lab. If you or a loved has been injured from using these products please seek immediate medical attention. Our law firm is presently investigating injuries and eye infections from the use of this product.

Contact us today for a free confidential case review.

Fire Star – Dura Star Balloon Catheters Recall

The FDA along with Cordis Corporation have issued a Class I recall of All Fire Star and Dura Star balloon catheters.

The defective medical device lots recalled are13173912 through 13315455, plus 52 additional lots above 13315455. Balloon catheters are used in a medical procedure (known as percutaneous transluminal coronary angioplasty or PTCA) to open narrowed or blocked blood vessels or arteries of the heart.

Products manufactured in Mexico from February, 2007 through December, 2007 and distributed worldwide from March 26, 2007 through January 8, 2008. Dura Star™ RX was distributed in the U.S. on August 29, 2007 and Fire Star™ RX was distributed in the U.S. on August 31, 2007.

The product has a potential for slow deflation or no deflation of the angioplasty balloon when inserted into the artery or other blood vessels. This may potentially result in a total blockage of the artery or blood vessels, resulting in a change in the heart rate or heart rhythm, injury to the heart artery, a heart attack, need for a surgical procedure, or death.

Consumers with questions may contact Cordis, Inc. at 1-786-313-2000

For Legal Questions and assistance call 1-866-242-0905 or visit the Fire Star Recall section.

Thomas Toymakers to Pay 30 Million Dollars Settlement

The maker of “Thomas & Friends Wooden Railway” toys has agreed to pay $30 million to settle a nationwide class-action lawsuit by thousands of families who purchased lead-tainted products, a plaintiffs’ attorney said Wednesday.Under the deal, Oak Brook-based RC2 Brands will offer cash refunds or replacement toys, plus what the company calls a bonus toy; it also promises to implement new quality controls, said Jay Edelson, a plaintiffs’ attorney in the case.

“We believe this really is the first step toward cleaning up the problem of lead paint in toys,” the Chicago attorney said. “It will put a lot of pressure on other companies to step up and act morally. We hope this becomes a problem of the past.”

The lawsuit was filed in the Circuit Court of Cook County last year, and the court gave the settlement preliminary approval on Tuesday. The judge is expected to give final approval at a hearing set for May 6, Edelson said.

This is the latest string in Toy Recalls and Defective Products recently in the US and Abroad.

Here is a short list from the recall and Consumers can also contact RC2 at (866) 725-4407 between 8 a.m. and 5 p.m. CT Monday through Friday or visit the firm’s Website at http://recalls.rc2.com

The front of the packaging has the logo “Thomas & Friends Wooden Railway” in the upper left-hand corner.

A tracking code may be located on the bottom of some of the products. Toys marked with codes containing “WJ” and “AZ” are not included in the recall.

The All-Black Cargo Car, included only in the Brendam Fishing Dock Set, is labeled “CARGO CAR” and has either no tracking code or one of the following codes on its undersides: 26833i, 28233i, 23243i00, 24643i00, 25343i00, 27443i00, 32043i00, 34743i00, 01553i00, 04553i00, 13353i00, 14753i00, 15453i00, 18353i00.

The toad vehicle with brake lever is labeled “TOAD” and has the tracking code 16560W000 on its underside. The Olive Green Sodor Cargo Box says “SODOR” on the side. The box was included only in the Deluxe Cranky the Crane Set.

The All-Green Maple Tree Top and Green Signal Base accessories were included only in Conductor’s Figure 8 Sets.

Cargo cars sold in other sets are not included in the recall.

If you believe that you have been adversely affected by a toy recall you can visit www.resource4thepeople.com for more information and legal help.

Merck Meningitis Shot Recall List

Merck Meningitis HIB Shot Recall involves ten lots of Hib vaccine and two lots of a vaccine for both Hib and hepatitis B.

Below is the recall list from the FDA. We will post more information as it becomes available.

Certain Lots of PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] and COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine]
NDC 0006-4897-00 and 0006-4898-00

DATE RECALL INITIATED:

December 11, 2007

PRODUCT / LOT NUMBER / EXPIRATION DATE:
PRODUCT DESCRIPTION LOT # EXP. DATE
PedvaxHIB® 0677U 11 January 2010
PedvaxHIB® 0820U 12 January 2010
PedvaxHIB® 0995U 16 January 2010
PedvaxHIB® 1164U 18 January 2010
PedvaxHIB® 0259U 17 October 2009
PedvaxHIB® 0435U 18 October 2009
PedvaxHIB® 0436U 19 October 2009
PedvaxHIB® 0437U 19 October 2009
PedvaxHIB® 0819U 09 January 2010
PedvaxHIB® 1167U 10 January 2010
COMVAX® 0376U 05 January 2010
COMVAX® 0377U 08 January 2010

MANUFACTURER:

Merck & Co., Inc.
West Point, PA

REASON:

These lots of PedvaxHIB and COMVAX are being recalled due to lack of assurance of product sterility.

More on Defective Drugs

Next Page »